JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
15/12/23 - 17:38
Diasorin Board of Directors approves 2024-2027 Business Plan (294.02 KB)
06/11/23 - 15:44
Diasorin and Gilead Sciences collaborate to develop a Fully Automated Diagnostic Assay for Hepatitis Delta Virus on Diasorin’s LIAISON XL® for the U.S. Market (506.97 KB)
03/11/23 - 15:51
Third Quarter results confirm guidance for Fiscal Year 2023 (822.89 KB)
24/10/23 - 15:03
Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com (574.08 KB)
27/07/23 - 14:27
Update 2023 Annual Calendar of Corporate Events (104.1 KB)
27/07/23 - 13:18
Revenues at constant perimeter of consolidation and ex-Covid up 5% at CER in Q2. FY 2023 Guidance Confirmed (598.06 KB)
17/07/23 - 7:03
DiaSorin launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease (510.4 KB)
03/07/23 - 11:48
Suspension of the effectiveness of the disqualifying accessory administrative sanction imposed by CONSOB to the Chief Executive Officer Mr. Carlo Rosa (102.52 KB)
13/06/23 - 15:18
DiaSorin launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark (578.05 KB)
07/06/23 - 14:40
Communication of total amount of voting rights (7 June 2023) (141.14 KB)
05/06/23 - 21:58
Administrative sanctions imposed by CONSOB in connection with the alleged breach to disclose obligations relating to inside information. Action for annulment. (107.91 KB)
26/05/23 - 7:10
DIASORIN CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM (159.38 KB)
09/05/23 - 11:56
Q1’23 REVENUES CONFIRM GUIDANCE FOR FISCAL YEAR 2023 (675.79 KB)
28/04/23 - 12:52
Shareholders' Meeting 2023 (373.48 KB)
27/03/23 - 15:52
Update 2023 Annual Calendar of Corporate Events (483.89 KB)
27/03/23 - 14:38
Dividend coupon date correction (493.46 KB)
27/03/23 - 13:35
REVENUE GROWTH, STRONG PROFITABILITY AND ROBUST CASH FLOW GENERATION IN 2022. PROPOSED ORDINARY DIVIDEND OF €1.10 PER SHARE (334.51 KB)
17/03/23 - 22:05
DiaSorin Simplexa COVID Flu assay received U.S. FDA 510(K) clearance (155.02 KB)
28/02/23 - 16:06
Sale of Flow Cytometry and Imaging business from DiaSorin to Cytek® Biosciences completed (130.89 KB)
13/02/23 - 22:03
CYTEK BIOSCIENCES TO ACQUIRE FLOW CYTOMETRY AND IMAGING BUSINESS FROM DIASORIN (165.22 KB)
07/02/23 - 12:01
Update 2023 Annual Calendar of Corporate Events (288.3 KB)
23/12/11 - 1:00
Financial instruments to employees (57.22 KB)
19/12/11 - 1:00
Clostridium Difficile toxins A and B in stool on LIAISON (available outside the US and Canada only) (192.66 KB)
19/11/11 - 1:00
Buy-back plan (35.47 KB)
18/11/11 - 1:00
Financial instruments to employees (56.82 KB)
11/11/11 - 1:00
The BoD approves Q3'11 results (334.35 KB)
28/10/11 - 2:00
Buy-back plan (103.99 KB)
25/10/11 - 2:00
Buy-back plan (104.72 KB)
18/10/11 - 2:00
Buy-back plan (136.18 KB)
17/10/11 - 2:00
2011-2015 Business Plan: a new business wave (195.1 KB)
10/10/11 - 2:00
New Chief Financial Officer (196.26 KB)
06/10/11 - 2:00
Cardinal Health: agreement extended to 2014 (192.57 KB)
04/10/11 - 2:00
Buy-back plan (204.92 KB)
01/09/11 - 2:00
Resignation of Chief Financial Officer (177.77 KB)
31/08/11 - 2:00
2011 Financial calendar update (176.4 KB)
03/08/11 - 2:00
The BoD approves H1'11 results (324.48 KB)
11/07/11 - 2:00
Voluntarily removal from the STAR segment (194.93 KB)
13/05/11 - 2:00
The BoD approves Q1'11 results (307.28 KB)
11/05/11 - 2:00
DiaSorin and Labcorp extend strategic business relationship (100.01 KB)
06/05/11 - 2:00
Agreement with Precision System Science Co., LTD (171.54 KB)
28/04/11 - 2:00
The Ordinary Shareholders' meeting approves the 2010 statutory financial statements and the dividend distribution (175.61 KB)
16/03/11 - 1:00
The BoD approves FY'10 results (368.28 KB)
16/03/11 - 1:00
Dividend information amendment (159.83 KB)
28/02/11 - 1:00
2011 Financial calendar update (179.92 KB)
19/02/11 - 1:00
Notice of change in share capital (5.28 KB)
18/02/11 - 1:00
Buy-back plan (134.06 KB)
17/02/11 - 1:00
Financial instruments to employees (56.37 KB)
16/02/11 - 1:00
Buy-back plan (105.2 KB)
15/02/11 - 1:00
Buy-back plan (91.38 KB)
14/02/11 - 1:00
The BoD approves Q4'10 results (161 KB)
31/01/11 - 1:00
Buy-back plan (105.05 KB)
29/01/11 - 1:00
Buy-back plan (105.2 KB)
28/01/11 - 1:00
Buy-back plan (105.04 KB)
27/01/11 - 1:00
Buy-back plan (105.04 KB)
26/01/11 - 1:00
FDA approves the LIAISON XL (194.2 KB)
25/01/11 - 1:00
Buy-back plan (105.22 KB)
24/01/11 - 1:00
Buy-back plan (104.72 KB)
21/01/11 - 1:00
Buy-back plan (105.05 KB)
20/01/11 - 1:00
Buy-back plan (91.39 KB)
19/01/11 - 1:00
Buy-back plan (105.31 KB)
18/01/11 - 1:00
Buy-back plan (35.47 KB)
17/01/11 - 1:00
Buy-back plan (134.01 KB)
17/01/11 - 1:00
The Sonic Healthcare Group chooses DiaSorin (181.71 KB)
16/01/11 - 1:00